| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/1997 | WO1997020934A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 06/12/1997 | WO1997020932A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020857A1 Cyclic dodecapeptide and process for the preparation thereof |
| 06/12/1997 | WO1997020856A1 ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES |
| 06/12/1997 | WO1997020850A1 3,4-DIHYDRO[1,2,4]THIADIAZINO[3,4-b]BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 06/12/1997 | WO1997020847A1 Tricyclic ibogaine analogs, their preparation and their use in treating substance abuse |
| 06/12/1997 | WO1997020844A1 β-METHYLCARBAPENEM DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME |
| 06/12/1997 | WO1997020843A1 Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 06/12/1997 | WO1997020842A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof |
| 06/12/1997 | WO1997020839A1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 06/12/1997 | WO1997020836A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
| 06/12/1997 | WO1997020835A1 Discodermolide compounds and pharmaceutical compositions containing them for cancer therapy |
| 06/12/1997 | WO1997020833A1 Benzofuran carboxamides and sulphonamides |
| 06/12/1997 | WO1997020824A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/12/1997 | WO1997020819A1 Composition for treating pain |
| 06/12/1997 | WO1997020818A1 Antimicrobial solution of formaldehyde substituted hydantoin and process for preparation |
| 06/12/1997 | WO1997020815A1 Compounds |
| 06/12/1997 | WO1997020812A1 RETINYL ESTERS OF α-HYDROXY ACIDS FOR TOPICAL IMPROVEMENT OF SKIN FUNCTION AND APPEARANCE |
| 06/12/1997 | WO1997020811A1 Vitamin d analogues |
| 06/12/1997 | WO1997020806A1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| 06/12/1997 | WO1997020805A1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity |
| 06/12/1997 | WO1997020802A1 Indane dimer compounds and their pharmaceutical use |
| 06/12/1997 | WO1997020580A1 Drug therapy |
| 06/12/1997 | WO1997020578A1 Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
| 06/12/1997 | WO1997020576A1 Vaccine compositions for intranasal administration comprising chitosan and use thereof |
| 06/12/1997 | WO1997020575A1 Targeted adenovirus vectors |
| 06/12/1997 | WO1997020574A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | WO1997020572A1 Pharmaceutical compositions for oral use including an nsaid and ceramides |
| 06/12/1997 | WO1997020570A1 Non-immunogenic and toleragenic platelet and red blood cell compositions |
| 06/12/1997 | WO1997020569A2 Bioartificial devices and cellular matrices therefor |
| 06/12/1997 | WO1997020567A1 Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders |
| 06/12/1997 | WO1997020566A1 Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders |
| 06/12/1997 | WO1997020565A1 Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders |
| 06/12/1997 | WO1997020564A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) |
| 06/12/1997 | WO1997020563A1 Ligands to enhance cellular uptake of biomolecules |
| 06/12/1997 | WO1997020562A1 Cisapride sustained release |
| 06/12/1997 | WO1997020561A1 Composition for treating pain |
| 06/12/1997 | WO1997020560A1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 06/12/1997 | WO1997020559A1 Use of fungicidal agents for selective decontamination of teeth and dental prostheses |
| 06/12/1997 | WO1997020558A1 Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes |
| 06/12/1997 | WO1997020557A1 Use of 2-aminobenzothiazoles for treating parkinson's disease and parkinsonian syndromes |
| 06/12/1997 | WO1997020556A1 Method for treating pain |
| 06/12/1997 | WO1997020555A1 Treatment or prevention of anoxic or ischemic brain injury with melatonin-containing compositions |
| 06/12/1997 | WO1997020554A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
| 06/12/1997 | WO1997020553A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 06/12/1997 | WO1997020552A1 Treatment of negative and cognitive symptoms of schizophrenia with glycine and its precursors |
| 06/12/1997 | WO1997020551A1 Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic |
| 06/12/1997 | WO1997020550A2 Improved method for preventing crystal formation in a dispersion of a liquid in a matrix |
| 06/12/1997 | WO1997020547A1 Endoparasiticidal agents |
| 06/12/1997 | WO1997020474A1 Method of increasing the reproduction rate of fish |
| 06/12/1997 | WO1997020468A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES |
| 06/12/1997 | WO1997012581A3 Novel composition containing an acid-labile omeprazole and process for its preparation |
| 06/12/1997 | WO1997012580A3 Novel composition containing an acid-labile benzimidazole and process for its preparation |
| 06/12/1997 | WO1997011667A3 Therapeutic applications using horse serum |
| 06/12/1997 | WO1997004668A3 Two-stage preparation |
| 06/12/1997 | DE19545463A1 Organisch-chemische Verbindung und Verfahren zu ihrer Herstellung Organic chemical compound and processes for their preparation |
| 06/12/1997 | CA2770851A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2591794A1 Process for preparing intermediates useful in preparing 2-chlorothiazole compounds |
| 06/12/1997 | CA2404957A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2239868A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | CA2239732A1 Method for treating pain |
| 06/12/1997 | CA2239728A1 Live attenuated vaccines based on cp45 hpiv-3 strain and method to ensure attenuation in such vaccines |
| 06/12/1997 | CA2239709A1 Method of diagnosing and treating epithelioma |
| 06/12/1997 | CA2239574A1 Non-immunogenic and toleragenic platelet and red blood cell compositions |
| 06/12/1997 | CA2239448A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 06/12/1997 | CA2239409A1 Use of fungicidal agents for selective decontamination of teeth and dental prostheses |
| 06/12/1997 | CA2239301A1 Composition for treating pain |
| 06/12/1997 | CA2239226A1 Transferrin binding proteins of pasteurella haemolytica and vaccines containing same |
| 06/12/1997 | CA2239203A1 Drug therapy |
| 06/12/1997 | CA2238893A1 Il-13 receptor polypeptide |
| 06/12/1997 | CA2238815A1 Composition for treating pain |
| 06/12/1997 | CA2238524A1 Tricyclic ibogaine analogs, their preparation and their use in treating substance abuse |
| 06/12/1997 | CA2238471A1 Treatment of the cns effects of hiv with vx-478, alone or in combination with azt or 3tc |
| 06/12/1997 | CA2238379A1 Ligands to enhance cellular uptake of biomolecules |
| 06/12/1997 | CA2238337A1 Hiv protease inhibitors |
| 06/12/1997 | CA2238306A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/12/1997 | CA2237495A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | CA2237478A1 Compounds |
| 06/12/1997 | CA2236265A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical use thereof |
| 06/12/1997 | CA2232489A1 Cisapride sustained release |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0778284A2 New 7-beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors |
| 06/11/1997 | EP0778283A2 Antibiotic macrolides |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778275A1 Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists |
| 06/11/1997 | EP0778274A1 Amidinohydrazones of ketones derived from benzo(b)furan, process for their preparation and medicaments containing these compounds |
| 06/11/1997 | EP0778271A2 Aminoalkyl-substituted benzo-heterocyclic compounds |
| 06/11/1997 | EP0778266A1 5-Amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of beta-amyloid protein production |
| 06/11/1997 | EP0778264A1 Tertiary amines having antimycotic and cholesterol lowering activity |
| 06/11/1997 | EP0778028A1 Compositions for the prevention and treatment of urogenital disorders, containing bismuth and one or more antimicrobials |
| 06/11/1997 | EP0778026A1 Remedy for endotoxinemia and multiple organ failure induced thereby |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0778024A1 Oral or intramuscular treatment of pancreatic cancer with water-insoluble S-Camptothecin of the closed lactone ring form |
| 06/11/1997 | EP0778023A1 Neuroprotective agents |
| 06/11/1997 | EP0778022A1 Treatment of chlamydia infectious diseases by rifamycin derivative |
| 06/11/1997 | EP0778020A1 Hair bleaching composition |
| 06/11/1997 | EP0777736A1 Functional modified hsv1-tk |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |